ClinVar Miner

Submissions for variant NM_001256007.3(PNPLA8):c.2161G>A (p.Glu721Lys)

dbSNP: rs1859698620
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV001089978 SCV001245031 uncertain significance Mitochondrial myopathy-lactic acidosis-deafness syndrome 2018-12-17 criteria provided, single submitter clinical testing A homozygous missense variant, NM_015723.3(PNPLA8):c.2161G>A, has been identified in exon 12 of 12 of the PNPLA8 gene. The variant is predicted to result in a minor amino acid change from glutamic acid to lysine at position 721 of the protein (NP_056538.1(PNPLA8):p.(Glu721Lys)). The glutamic acid residue at this position has very high conservation (100 vertebrates, UCSC), but is not located within a well established functional domain. In silico predictions for this variant are consistently pathogenic (Polyphen, SIFT, CADD, Mutation Taster). The variant is absent in population databases (gnomAD, dbSNP, 1000G). This variant has not been previously reported in clinical cases. Analysis of parental samples indicated this variant was paternally and maternally inherited. Based on the information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.